XML 19 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Cash Flows - USD ($)
11 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2018
Cash flows from operating activities:    
Net income (loss) attributable to ordinary shares $ (376,372) $ 6,865,501
Changes in operating assets and liabilities:    
Prepaid expenses (134,722) 99,722
Accrued professional fees, travel and other expenses 36,589 95,082
Accrued formation costs 0 0
Interest on investments held in Trust Account 0 (7,669,551)
Withdrawal of interest from Trust Account to pay operating expenses 0 750,000
Net cash provided by (used in) operating activities (474,505) 140,754
Cash flows from investing activities:    
Proceeds deposited into Trust Account (450,000,000) 0
Net cash used in investing activities (450,000,000) 0
Cash flows from financing activities:    
Proceeds from sale of Units in initial public offering 450,000,000 0
Proceeds from sale of Private Placement Warrants to Sponsor 11,000,000 0
Proceeds of notes payable from Sponsor 300,000 0
Payment of underwriters discounts (9,000,000) 0
Payment of accrued offering costs (1,178,422) 0
Repayment of notes payable from Sponsor (300,000) 0
Net cash provided by financing activities 450,846,578 0
Net change in cash 372,073 140,754
Cash at beginning of period 0 372,073
Cash at end of period 372,073 512,827
Supplemental disclosure of non-cash financing activities:    
Deferred underwriting compensation 15,750,000 0
Accrued offering costs 120,801 0
Class F ordinary shares    
Cash flows from operating activities:    
Net income (loss) attributable to ordinary shares 0 0
Cash flows from financing activities:    
Proceeds from sale of Class F ordinary shares to Sponsor $ 25,000 $ 0